[HTML][HTML] Visual acuity outcomes and anti–vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world …
TA Ciulla, RM Hussain, JS Pollack, DF Williams - Ophthalmology Retina, 2020 - Elsevier
Purpose This study assessed anti–vascular endothelial growth factor (VEGF) therapy
intensity and its relationship with visual acuity (VA) change in real-world neovascular age-
related macular degeneration (nAMD) patients. Design This retrospective analysis was
performed on a large database of aggregated, longitudinal, de-identified electronic medical
records from a geographically and demographically diverse sample of patients of United
States retina specialists (Vestrum Health Retina Database). Participants Treatment-naïve …
intensity and its relationship with visual acuity (VA) change in real-world neovascular age-
related macular degeneration (nAMD) patients. Design This retrospective analysis was
performed on a large database of aggregated, longitudinal, de-identified electronic medical
records from a geographically and demographically diverse sample of patients of United
States retina specialists (Vestrum Health Retina Database). Participants Treatment-naïve …